These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22535619)

  • 41. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.
    Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
    Carcinogenesis; 2012 Oct; 33(10):1889-96. PubMed ID: 22739025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beyond Neutrophils for Predicting Relapse and Remission in Ulcerative Colitis.
    El-Zimaity H; Shaffer SR; Riddell RH; Pai RK; Bernstein CN
    J Crohns Colitis; 2023 May; 17(5):767-776. PubMed ID: 36426876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?
    Rutka M; Milassin Á; Szepes Z; SzŰcs M; Nyári T; Bálint A; Bor R; Molnár T; Farkas K
    Scand J Gastroenterol; 2015 Aug; 50(8):985-90. PubMed ID: 25733077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
    Ponte A; Pinho R; Fernandes S; Rodrigues A; Alberto L; Silva JC; Silva J; Rodrigues J; Sousa M; Silva AP; Proença L; Freitas T; Leite S; Carvalho J
    Inflamm Bowel Dis; 2017 Dec; 23(12):2238-2244. PubMed ID: 28991857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remission.
    Rosenberg L; Lawlor GO; Zenlea T; Goldsmith JD; Gifford A; Falchuk KR; Wolf JL; Cheifetz AS; Robson SC; Moss AC
    Inflamm Bowel Dis; 2013; 19(4):779-84. PubMed ID: 23446338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis.
    Prossomariti A; Scaioli E; Piazzi G; Fazio C; Bellanova M; Biagi E; Candela M; Brigidi P; Consolandi C; Balbi T; Chieco P; Munarini A; Pariali M; Minguzzi M; Bazzoli F; Belluzzi A; Ricciardiello L
    Sci Rep; 2017 Aug; 7(1):7458. PubMed ID: 28785079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucosal gene transcription of ulcerative colitis in endoscopic remission.
    Arkteg CB; Goll R; Gundersen MD; Anderssen E; Fenton C; Florholmen J
    Scand J Gastroenterol; 2020 Feb; 55(2):139-147. PubMed ID: 31918598
    [No Abstract]   [Full Text] [Related]  

  • 49. Qing Hua Chang Yin inhibits the LPS-induced activation of the IL-6/STAT3 signaling pathway in human intestinal Caco-2 cells.
    Ke X; Hu G; Fang W; Chen J; Zhang X; Yang C; Peng J; Chen Y; Sferra TJ
    Int J Mol Med; 2015 Apr; 35(4):1133-7. PubMed ID: 25633437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
    Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mucosal Profiles of Immune Molecules Related to T Helper and Regulatory T Cells Predict Future Relapse in Patients With Quiescent Ulcerative Colitis.
    Fukaura K; Iboshi Y; Ogino H; Ihara E; Nakamura K; Nishihara Y; Nishioka K; Chinen T; Iwasa T; Aso A; Goto A; Haraguchi K; Akiho H; Harada N; Ogawa Y
    Inflamm Bowel Dis; 2019 May; 25(6):1019-1027. PubMed ID: 30668727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Correlations Between the Expression of MicroRNA-155 and Suppressor of Cytokine Signaling 1 in Colonic Mucosal Tissue and Disease Severity in Patients With Ulcerative Colitis].
    Zhang X; Jia HY; Song WX; Zhao HQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Jun; 46(3):334-340. PubMed ID: 38953257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
    Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
    Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic 'mucosal healing' and implication for management. Preliminary results.
    Pagnini C; Menasci F; Festa S; Rizzatti G; Corleto VD; Delle Fave MM; D'Ambra G; Di Giulio E; Delle Fave G
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3674-81. PubMed ID: 26502857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histological inflammatory activity can predict endoscopic relapse in patients with ulcerative colitis who have achieved mucosal healing.
    González-Partida I; Martínez-Lozano H; González-Lois C; Peligros I; Sánchez-Yuste R; Salas I; Matallana V; Bighelli F; Calvo M; Marín-Jiménez I; Salas C; Vera MI; Menchén L; González-Lama Y
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e796-e802. PubMed ID: 34334707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased mucosal IL-12 expression is associated with relapse of ulcerative colitis.
    Uchiyama K; Takagi T; Mizushima K; Kajiwara-Kubota M; Kashiwagi S; Toyokawa Y; Tanaka M; Hotta Y; Kamada K; Ishikawa T; Konishi H; Kishimoto M; Naito Y; Itoh Y
    BMC Gastroenterol; 2021 Mar; 21(1):122. PubMed ID: 33730998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-time Endoscopy-Guided Measurement of Rectal Mucosal Admittance Is a Novel and Safe Method for Predicting Ulcerative Colitis Relapse.
    Taida T; Arai M; Fujie M; Akizue N; Ishikawa K; Ohta Y; Hamanaka S; Ishigami H; Okimoto K; Saito K; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Kato N
    Inflamm Bowel Dis; 2018 Oct; 24(11):2360-2365. PubMed ID: 29931368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis: a prospective study.
    Jauregui-Amezaga A; López-Cerón M; Aceituno M; Jimeno M; Rodríguez de Miguel C; Pinó-Donnay S; Zabalza M; Sans M; Ricart E; Ordás I; González-Suárez B; Cuatrecasas M; Llach J; Panés J; Pellise M
    Inflamm Bowel Dis; 2014 Jul; 20(7):1187-93. PubMed ID: 24874457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Applicability of endoscopic indices in the determination of disease activity in patients with ulcerative colitis.
    Kucharski M; Karczewski J; Mańkowska-Wierzbicka D; Karmelita-Katulska K; Grzymisławski M; Kaczmarek E; Iwanik K; Rzymski P; Swora-Cwynar E; Linke K; Dobrowolska A
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):722-30. PubMed ID: 26894632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Is histological remission of ulcerative colitis achievable?].
    Knyazev OV; Kagramanova AV; Khomeriki SG; Parfenov AI
    Ter Arkh; 2021 Aug; 93(8):975-981. PubMed ID: 36286895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.